Feltl & Co Downgrades Evoke Pharma (EVOK) to Sell
Tweet
Share
E-mailGet Alerts EVOK Hot Sheet
Price: $11.00 --0%
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Feltl & Co downgraded Evoke Pharma (NASDAQ: EVOK) from Strong Buy to Sell with a price target of $0.20.
For an analyst ratings summary and ratings history on Evoke Pharma click here. For more ratings news on Evoke Pharma click here.
Shares of Evoke Pharma closed at $10.73 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Argus Downgrades Restaurant Brands International (QSR) to Hold
- Gordon Haskett Downgrades Lowe's (LOW) to Hold (3)
- BofA Securities Downgrades Nike (NKE) to Underperform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
